Hikma Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	217	188	205	270	426
Cash & Short-Term Investments	217	188	205	270	426
Cash Growth	15.43%	-8.29%	-24.07%	-36.62%	31.89%
Accounts Receivable	1,061	949	824	809	816
Other Receivables	18	24	49	32	60
Total Trade Receivables	1,079	973	873	841	876
Inventory	1,106	986	891	776	695
Other Current Assets	241	116	131	112	97
Total Current Assets	2,643	2,263	2,100	1,999	2,094
Net Property, Plant & Equipment	1,448	1,326	1,141	1,081	1,146
Other Intangible Assets	777	774	712	735	607
Goodwill	393	382	388	389	285
Long-Term Investments	11	11	10	10	10
Other Long-Term Assets	399	377	329	257	230
Total Assets	5,671	5,133	4,680	4,471	4,372
Accounts Payable	715	650	568	476	468
Accrued Expenses	74	78	74	73	57
Current Portion of Long-Term Debt	106	642	150	139	112
Current Portion of Leases	8	11	11	9	9
Other Current Liabilities	550	597	536	380	370
Total Current Liabilities	1,453	1,978	1,339	1,077	1,016
Long-Term Debt	1,445	607	975	1,074	651
Long-Term Leases	45	46	55	61	74
Other Long-Term Liabilities	122	181	102	111	164
Total Long-Term Liabilities	1,612	834	1,132	1,246	889
Total Liabilities	3,065	2,812	2,471	2,323	1,905
Common Stock	40	40	40	40	42
Additional Paid-in Capital	282	282	282	282	282
Accumulated Other Comprehensive Income	-285	-374	-282	-279	-60
Retained Earnings	2,556	2,362	2,158	2,092	2,189
Total Common Shareholders' Equity	2,593	2,310	2,198	2,135	2,453
Minority Interest	13	11	11	13	14
Shareholders' Equity	2,606	2,321	2,209	2,148	2,467
Total Liabilities & Equity	5,671	5,133	4,680	4,471	4,372
Total Debt	1,604	1,306	1,191	1,283	846
Net Cash (Debt)	-1,387	-1,118	-986	-1,013	-420
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-6.23	-5.00	-4.43	-4.50	-1.80
Book Value	2,593	2,310	2,198	2,135	2,453
Book Value Per Share	11.64	10.34	9.88	9.49	10.53
Tangible Book Value	1,423	1,154	1,098	1,011	1,561
Tangible Book Value Per Share	6.39	5.16	4.94	4.50	6.70